Effects of Subcutaneous Methotrexate in Patients with Refractory Uveitis and Chorioretinitis

CONCLUSIONS: The study confirmed that in patients with uveitis or chorioretinitis who had a refractory response to treatment with other immunosuppressive agents, subcutaneous MTX showed improved treatment efficacy.PMID:37899284 | DOI:10.3341/kjo.2023.0073
Source: Korean Journal of Ophthalmology : KJO - Category: Opthalmology Authors: Source Type: research